Apellis Pharmaceuticals, Inc. (APLS) vs Blueprint Medicines Corporation (BPMC)
Detailed comparison between Apellis Pharmaceuticals, Inc., Blueprint Medicines Corporation.Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)Blueprint Medicines Corporation (BPMC)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
Blueprint Medicines Corporation
BPMC
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | Blueprint Medicines Corporation (BPMC) |
|---|---|---|
| Current Price | $17.30 | $97.17 |
| Change | -0.51 (-2.86%) | -1.59 (-1.61%) |
| Market Cap | $2.17B | $6.28B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -20.60 | -103.37 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $43.99 | $121.90 |
| 52-Week Low | $16.65 | $73.04 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.60 | $-2.51 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | -10.92% | -39.49% | -59.78% | -47.42% | 23.31% | 23.31% |
| BPMC | 20.20% | -5.99% | -10.07% | 49.31% | 289.38% | 289.38% |